source
- Five BioSpace NextGen companies debut on US markets in 2026, four actively hiringBioSpace NextGen honorees accounted for about one third of the 14 U.S. biotech companies that went public in 2026. The five companies together raised roughly $1.5 billion in IPO proceeds, includin…
- Attovia Therapeutics raises $289 million in IPO to fund anti-itch drug developmentAttovia Therapeutics completed an initial public offering that generated $289 million in gross proceeds. The company sold 17 million shares at $17 each, exceeding its original target of $182.4 mill…